ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 151 filers reported holding ANIKA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,613,000 | -10.8% | 47,987 | +12.0% | 0.06% | -9.2% |
| Q3 2018 | $1,808,000 | -57.8% | 42,853 | -61.8% | 0.06% | -79.0% |
| Q4 2013 | $4,280,000 | +55.8% | 112,169 | -2.4% | 0.31% | +17.0% |
| Q3 2013 | $2,747,000 | -10.2% | 114,969 | -36.1% | 0.26% | -12.6% |
| Q2 2013 | $3,059,000 | – | 179,931 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |